Beyond access: the evolution of Portugal’s pharmacy-based vaccination strategy and the future role of AI-driven outreach

Vaccination programmes increasingly face a paradox: expanding access does not necessarily translate into coverage at policy targets. Portugal provides an instructive example. The integration of community pharmacies into seasonal influenza and COVID-19 vaccination created more than 3,500 vaccination points and approximately 70% of influenza doses were administered in pharmacies in 2023–2024. The pharmacy share then fell to under 46% by 2025–2026, while total influenza doses remained broadly stable (2.41 to 2.56 million per season). This indicates a redistribution of doses across settings rather than a loss of vaccination activity; changes in age eligibility, high-dose vaccination for adults aged ≥85 years in SNS units, and invitation and recall activity may all have contributed. Influenza coverage among adults aged ≥65 years remained below the World Health Organization target of 75%, at 70.5% in 2024–2025 and 73.0% in 2025–2026. This suggests that, residual under-vaccination reflects barriers beyond physical access. The authors use “activation gap” descriptively for potentially addressable interruptions between eligibility and vaccination. Portugal already uses registry-based invitations and reminders, the open question is what a conversational layer, scripted or based on generative AI, could add. Evidence is relatively strong for reminders, growing for scripted conversational interventions and preliminary for generative AI. The authors therefore propose a registry-based randomised comparison of existing recall, existing recall plus a scripted conversational intervention, and existing recall plus a generative-AI conversational intervention, with incremental vaccination, safety, equity, trust and cost per additional vaccinated person as outcomes.

Authors

Institutions

Publication Details

Journal
Frontiers in Public Health
Published
2026-11-18
DOI
https://doi.org/10.3389/fpubh.2026.2007800
Primary Topic
Vaccine Coverage and Hesitancy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Beyond access: the evolution of Portugal’s pharmacy-based vaccination strategy and the future role of AI-driven outreach

Fabíola M.T.A. Costa, Francisco Goiana-da-Silva, Sónia Romano, Hutan Ashrafian et al.
4 links
Frontiers in Public Health
Vaccine Coverage and Hesitancy
article

Beyond access: the evolution of Portugal’s pharmacy-based vaccination strategy and the future role of AI-driven outreach

Fabíola M.T.A. Costa, Francisco Goiana-da-Silva, Sónia Romano, Hutan Ashrafian, Ema Paulino, Fernando Dias Correia, Duarte Tude Graça, Pedro Tamudjim-Fonseca, João Pereira, Rik Renard, Tomás Portas, Pedro Silva, Nuno Cardoso, António Teixeira Rodrigues
article en

Abstract

Vaccination programmes increasingly face a paradox: expanding access does not necessarily translate into coverage at policy targets. Portugal provides an instructive example. The integration of community pharmacies into seasonal influenza and COVID-19 vaccination created more than 3,500 vaccination points and approximately 70% of influenza doses were administered in pharmacies in 2023–2024. The pharmacy share then fell to under 46% by 2025–2026, while total influenza doses remained broadly stable (2.41 to 2.56 million per season). This indicates a redistribution of doses across settings rather than a loss of vaccination activity; changes in age eligibility, high-dose vaccination for adults aged ≥85 years in SNS units, and invitation and recall activity may all have contributed. Influenza coverage among adults aged ≥65 years remained below the World Health Organization target of 75%, at 70.5% in 2024–2025 and 73.0% in 2025–2026. This suggests that, residual under-vaccination reflects barriers beyond physical access. The authors use “activation gap” descriptively for potentially addressable interruptions between eligibility and vaccination. Portugal already uses registry-based invitations and reminders, the open question is what a conversational layer, scripted or based on generative AI, could add. Evidence is relatively strong for reminders, growing for scripted conversational interventions and preliminary for generative AI. The authors therefore propose a registry-based randomised comparison of existing recall, existing recall plus a scripted conversational intervention, and existing recall plus a generative-AI conversational intervention, with incremental vaccination, safety, equity, trust and cost per additional vaccinated person as outcomes.

Frontiers in Public HealthVol. 14
University of Lisbon (PT), University of Beira Interior (PT), Utah Department of Health (US), Instituto de Investigação Científica Tropical (PT), Associação Nacional das Farmácias (PT), Sword Health, SA (Portugal) (PT), Imperial College London (GB), Universidade Nova de Lisboa (PT), University of Minho (PT)
Good health and well-being, Reduced inequalities
Vaccine Coverage and Hesitancy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon